hum-20220301

0000049071-22-000024.txt : 20220301 0000049071-22-000024.hdr.sgml : 20220301 20220301073255 ACCESSION NUMBER: 0000049071-22-000024 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20220301 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220301 DATE AS OF CHANGE: 20220301 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HUMANA INC CENTRAL INDEX KEY: 0000049071 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] IRS NUMBER: 610647538 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-05975 FILM NUMBER: 22693957 BUSINESS ADDRESS: STREET 1: 500 W MAIN ST CITY: LOUISVILLE STATE: KY ZIP: 40202 BUSINESS PHONE: 5025801000 MAIL ADDRESS: STREET 1: 500 W. MAIN ST CITY: LOUISVILLE STATE: KY ZIP: 40202 FORMER COMPANY: FORMER CONFORMED NAME: EXTENDICARE INC DATE OF NAME CHANGE: 19740404 FORMER COMPANY: FORMER CONFORMED NAME: HERITAGE HOUSE OF AMERICA INC DATE OF NAME CHANGE: 19671129 8-K 1 hum-20220301.htm 8-K hum-20220301

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 1, 2022 (March 1, 2022)

Humana Inc.


(Exact name of registrant as specified in its charter)


Delaware	001-5975	61-0647538
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

500 West Main Street, Louisville, Kentucky 40202

(Address of principal executive offices, including zip code)

(502) 580-1000

(Registrant’s telephone number, including area code)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol	Name of each exchange on which registered
Common Stock	HUM	New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(d) Effective March 1, 2022, the Board of Directors (the “Board”) of Humana Inc. (the “Company”) expanded its number of authorized directors from thirteen to fourteen and elected David T. Feinberg, M.D. as a director of the Company.

The Board of Directors has determined that (i) Dr. Feinberg is independent within the meaning of the New York Stock Exchange’s director independence standards; and (ii) there are no material transactions involving Dr. Feinberg and the Company. Under the agreement dated as of February 21, 2022 (the “Agreement”), between the Company and Starboard Value LP and certain of its affiliated entities and natural persons as set forth in the signature pages thereto (collectively, “Starboard”), the Company and Starboard have mutually agreed to Dr. Feinberg’s service.

Dr. Feinberg will be compensated in accordance with the Company’s standard compensation policies and practices for the Board, the components of which were disclosed by the Company in its current report on Form 8-K filed with the U.S. Securities and Exchange Commission on August 20, 2021. In connection with his election to the Board, Dr. Feinberg also will be granted restricted stock units (RSUs) in accordance with the Company’s director compensation program. Dr. Feinberg has not yet been appointed to any committees of the Board.

On March 1, 2022, the Company issued a press release announcing the election of Dr. Feinberg, a copy of which is attached hereto as Exhibit 99.1, and is incorporated by reference herein.

Item 9.01 Financial Statements and Exhibits.

(d)Exhibits:


Exhibit No.			Description

99.1			Press Release
104			Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.


HUMANA INC.

BY:			/s/ Cynthia H. Zipperle
			Cynthia H. Zipperle
			Senior Vice President, Chief Accounting Officer and Controller
			(Principal Accounting Officer)

Dated: March 1, 2022

EX-99.1 2 exhibit991.htm EX-99.1 Document

n e w s r e l e a s e

Exhibit 99.1

FOR MORE INFORMATION, CONTACT

Lisa Stoner

Investor Relations

Humana Inc.

502-580-2652

lstamper@humana.com

Mark Taylor

Corporate Communications

Humana Inc.

317-753-0345

mtaylor108@humana.com

Humana Elects David T. Feinberg, M.D. to Board of Directors

LOUISVILLE, Ky. — Mar. 1, 2022 — Humana Inc. (NYSE: HUM) announced today that David T. Feinberg, M.D., M.B.A., has been elected as a member of the Company’s Board of Directors. He currently serves as the President, CEO and member of the Board of Directors of Cerner, a supplier of health information technology services, devices and hardware.

Dr. Feinberg is a seasoned industry executive with 25-plus years in senior healthcare leadership roles. Prior to joining Cerner, Dr. Feinberg served as Vice President of Google Health, where he led Google’s worldwide health efforts, bringing together groups from across Google and Alphabet that used artificial intelligence, product expertise and hardware to tackle some of healthcare’s biggest challenges, and was responsible for organizing and innovating Google’s various healthcare initiatives. Before that, Dr. Feinberg served as President and CEO of Geisinger Health and spent more than twenty years at the UCLA, where he served in a number of leadership roles, including President, CEO and Associate Vice Chancellor of UCLA Health Sciences, Vice Chancellor and CEO for the UCLA Hospital System, and CEO of UCLA’s Ronald Reagan Medical Center.

“David is a proven executive with tremendous experience in the healthcare industry, leading organizations focused on technology and digital innovation to improve clinical care,” said Humana Chairman of the Board Kurt J. Hilzinger. “His background, patient-centric mindset, operating experience and expertise in guiding systems transformations will benefit Humana as the Company continues to grow, innovate and execute on its strategy. We are pleased to welcome David to the Humana Board and look forward to benefiting from his perspectives as the Company continues to improve the customer experience, reduce costs and deliver for its shareholders.”

His election brings the number of Humana directors to 14.

n e w s r e l e a s e

About Humana

Humana Inc. (NYSE: HUM) is committed to helping our millions of medical and specialty members achieve their best health. Our successful history in care delivery and health plan administration is helping us create a new kind of integrated care with the power to improve health and well-being and lower costs. Our efforts are leading to a better quality of life for people with Medicare, families, individuals, military service personnel, and communities at large.

To accomplish that, we support physicians and other health care professionals as they work to deliver the right care in the right place for their patients, our members. Our range of clinical capabilities, resources and tools – such as in-home care, behavioral health, pharmacy services, data analytics and wellness solutions – combine to produce a simplified experience that makes health care easier to navigate and more effective.

More information regarding Humana is available to investors via the Investor Relations page of the company’s website at humana.com, including copies of:

a.Annual reports to stockholders

b.Securities and Exchange Commission filings

c.Most recent investor conference presentations

d.Quarterly earnings news releases and conference calls

e.Calendar of events

f.Corporate Governance information

# # #

EX-101.SCH 3 hum-20220301.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 hum-20220301_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Pre-commencement Tender Offer Pre-commencement Tender Offer Amendment Flag Amendment Flag Entity Address, State or Province Entity Address, State or Province Entity Tax Identification Number Entity Tax Identification Number Title of 12(b) Security Title of 12(b) Security Entity File Number Entity File Number Written Communications Written Communications Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Entity Emerging Growth Company Entity Emerging Growth Company Trading Symbol Trading Symbol Document Period End Date Document Period End Date Soliciting Material Soliciting Material Document Type Document Type City Area Code City Area Code Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line One Entity Registrant Name Entity Registrant Name Local Phone Number Local Phone Number Entity Address, City or Town Entity Address, City or Town Cover [Abstract] Cover [Abstract] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Central Index Key Entity Central Index Key Security Exchange Name Security Exchange Name EX-101.PRE 5 hum-20220301_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 6 image.jpg HUM LOGO begin 644 image.jpg MB5!.1PT*&@H -24A$4@ 8T !O" 8 %G6ZQZ 7-21T( KLX< MZ0 1G04U! "QCPO\804 )<$A9

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htm IDEA: XBRL DOCUMENT v3.22.0.1

Cover

Feb. 28, 2022

Cover [Abstract]

Document Type 8-K

Document Period End Date Mar. 01, 2022

Entity Registrant Name Humana Inc.

Entity Incorporation, State or Country Code DE

Entity File Number 001-5975

Entity Tax Identification Number 61-0647538

Entity Address, Address Line One 500 West Main Street

Entity Address, City or Town Louisville

Entity Address, State or Province KY

Entity Address, Postal Zip Code 40202

City Area Code 502

Local Phone Number 580-1000

Written Communications false

Soliciting Material false

Pre-commencement Tender Offer false

Pre-commencement Issuer Tender Offer false

Title of 12(b) Security Common Stock

Trading Symbol HUM

Security Exchange Name NYSE

Entity Emerging Growth Company false

Entity Central Index Key 0000049071

Amendment Flag false

Cover	Feb. 28, 2022
Cover [Abstract]
Document Type	8-K
Document Period End Date	Mar. 01, 2022
Entity Registrant Name	Humana Inc.
Entity Incorporation, State or Country Code	DE
Entity File Number	001-5975
Entity Tax Identification Number	61-0647538
Entity Address, Address Line One	500 West Main Street
Entity Address, City or Town	Louisville
Entity Address, State or Province	KY
Entity Address, Postal Zip Code	40202
City Area Code	502
Local Phone Number	580-1000
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Title of 12(b) Security	Common Stock
Trading Symbol	HUM
Security Exchange Name	NYSE
Entity Emerging Growth Company	false
Entity Central Index Key	0000049071
Amendment Flag	false